Printer Friendly

SOMANETICS CORPORATION SECURITIES WILL TRADE IN NASDAQ NATIONAL MARKET

SOMANETICS CORPORATION SECURITIES WILL TRADE IN NASDAQ NATIONAL MARKET
 TROY, Mich., Aug. 5 /PRNewswire/ -- The Common Shares and Class B Warrants of Somanetics Corporation will begin trading in the NASDAQ National Market on Aug. 18, 1992, Gary D. Lewis, Somanetics' chairman, president and chief executive officer, announced. The trading symbols for Somanetics' Common Shares and Class B Warrants will remain SMTS and SMTSZ, respectively.
 Somanetics Corporation develops, manufactures and markets computer- based medical diagnostic and monitoring equipment using In Vivo Optical Spectroscopy (INVOS(R)) technology. The company's INVOS 3100 Cerebral Oximeter is the first product of its kind to monitor, noninvasively, directly and continuously, the oxygen saturation of the blood in portions of an adult's brain. In July, Somanetics announced that the INVOS 3100 Cerebral Oximeter had been cleared by the Food and Drug Administration for marketing, promotion and commercial sales. The INVOS 3100 Cerebral Oximeter will be marketed to adult critical care sites, including operating rooms and intensive care units, recovery rooms and emergency rooms.
 Lewis noted that Somanetics' entry into the NASDAQ National Market provides brokers and others with immediate access to the best bid and asked prices and other information about the company's shares throughout the trading day. Those prices are available over more than 190,000 electronic terminals in brokers' offices throughout the world. Trading data are also distributed widely through wire services for selective distribution by newspapers and radio and television stations. In addition to increased market visibility, NASDAQ gives Somanetics the advantage of multiple market makers that compete to offer the best bid and asked prices, as opposed to a single specialist on the floor of a stock exchange.
 Somanetics Corporation, headquartered in Troy, currently has 41 employees. Interested parties should contact the Corporate Communications Department for company background information.
 -0- 8/5/92
 /CONTACT: Mary Ann Robb of Somanetics, 313-689-3050/
 (SMTS) CO: Somanetics Corporation ST: Michigan IN: MTC SU:


ML -- DE002 -- 6955 08/05/92 09:17 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 5, 1992
Words:325
Previous Article:JOHN WANAMAKER WELCOMES THE DONNA KARAN COLLECTION TO ITS TRIBOUT DEPARTMENT IN THE CENTER CITY STORE
Next Article:APPROVALS GAINED FOR ROHM AND HAAS-ELF ATOCHEM JOINT VENTURE
Topics:


Related Articles
SOMANETICS CORPORATION ANNOUNCES REDEMPTION OF CLASS A, CLASS B WARRANTS
SOMANETICS ANNOUNCES EXTENDED REDEMPTION PERIOD FOR CLASS B WARRANTS AND REVISED SHIPPING SCHEDULE
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO DEC. 29, 1993
SOMANETICS ANNOUNCES COMPLETION OF STOCK OFFERING
SOMANETICS SECURITIES RE-LISTED ON NASDAQ IN THE SMALLCAP MARKET
SOMANETICS SECURITIES RE-LISTED ON NASDAQ IN THE SMALLCAP MARKET
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO AUGUST 4, 1995
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO NOVEMBER 9, 1995
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO MARCH 20, 1996
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO SEPTEMBER 26, 1996

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters